Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial - Mu, Y; Bao, X; Eliaschewitz, F G (The Lancet Diabetes & Endocrinology, 2024)
et al.